pilocarpine has been researched along with ly382884 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleakman, D; Bortolotto, ZA; Clarke, VR; Collingridge, GL; Ebinger, G; Ho, KH; Khan, GM; Lodge, D; Michotte, Y; O'Neill, MJ; Ogden, A; Ornstein, PL; Smolders, I; Stables, JP; Warre, R; Weiss, B | 1 |
1 other study(ies) available for pilocarpine and ly382884
Article | Year |
---|---|
Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures.
Topics: Action Potentials; Animals; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Electroshock; Epilepsy; Excitatory Amino Acid Antagonists; Humans; In Vitro Techniques; Isoquinolines; Kainic Acid; Limbic System; Male; Mice; Pilocarpine; Rats; Rats, Wistar; Receptors, Kainic Acid; Substrate Specificity; Treatment Outcome | 2002 |